You know, in Asia, and before we do thrombolysis in my clinical practice, I am afraid of bleeding because it’s based on the data in Asian people. The risk of bleeding with antithrombotics is higher than other people. But when we do some clinical trial in my country, we found that in Asia, the TPA thrombolysis is safe, at least equally effective and safe with other people in the world. But I think it’s for Asians, I think one more thing can improve the benefit of thrombolysis is how we can do it quickly...
You know, in Asia, and before we do thrombolysis in my clinical practice, I am afraid of bleeding because it’s based on the data in Asian people. The risk of bleeding with antithrombotics is higher than other people. But when we do some clinical trial in my country, we found that in Asia, the TPA thrombolysis is safe, at least equally effective and safe with other people in the world. But I think it’s for Asians, I think one more thing can improve the benefit of thrombolysis is how we can do it quickly. Because it’s now in developing countries, very rarely we can start intravenous thrombolysis in the first one hour after the onset. So I wish I can do it quickly. Maybe we need a mobile stroke unit. It can help us to do thrombolysis very quickly. And one more thing is we hope we can have the new neuroprotection because neuroprotection is very easy to use and we don’t need to train doctors to use neuroprotection. So we can use neuroprotection everywhere if they got the benefit before we can go further with IV thrombolysis. Maybe it may be more effective and safer for intravenous thrombolysis.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.